The attendees of the first course starting on September 14, 2010 in Freiburg, come from the German Health Authority Paul-Ehrlich-Institut, the Federal Institute for Vaccine and Biomedicines, from pharmaceutical companies and from specialists in drug development and regulatory affairs. The companies sending attendees are Novartis, Merck Serono, Talecris, Xendo GmbH and Dr. Regenold GmbH.

If you are interested - you can start the course at any time. Or you can book individual Seminars according to your needs.
Further details see here